CAR138 T Cells are a CD138 targeted CAR T Cell therapy being developed at the University of North Carolina.
| SparkCures ID | 335 |
|---|---|
| Generic Name | ATLCAR.CD138 |
| Treatment Classifications | |
| Treatment Targets |
There are no resources, links or videos to display for this treatment.